Entry Detail



General Information

Database ID:exR0275354
RNA Name:hsa-miR-155-3p
RNA Type:miRNA
Chromosome:chr21
Starnd:+
Coordinate:
Start Site(bp):25574022End Site(bp):25574043
External Links:hsa-miR-155-3p



Disease Information

Disease Name:Advanced Adenoma
Disease Category:Cancers
MeSH ID:D000236
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Adenoma//Adenomas//Adenoma, Follicular//Adenomas, Follicular//Follicular Adenoma//Follicular Adenomas//Adenoma, Trabecular//Adenomas, Trabecular//Trabecular Adenoma//Trabecular Adenomas//Adenoma, Monomorphic//Adenomas, Monomorphic//Monomorphic Adenoma//Monomorphic Adenomas//Adenoma, Papillary//Adenomas, Papillary//Papillary Adenoma//Papillary Adenomas//Adenoma, Basal Cell//Adenomas, Basal Cell//Basal Cell Adenoma//Basal Cell Adenomas//Adenoma, Microcystic//Adenomas, Microcystic//Microcystic Adenoma//Microcystic Adenomas



Expression Detail

GEO ID:GSE25609
Description:Plasma microRNA profiling by microarray elucidates several candidate biomarkers for colorectal cancer screening
Experimental Design:Cancer vs Control
Case Disease Type:Advanced Adenoma
Case Disease SubType:NA
Case Sample:Advanced Adenoma Post surgery
Control Sample:Control
Number of Case:20
Number of Control:20
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ADCY3
chr2
24819169
24919839
-
OTUB1
chr11
63985853
64001811
+
AC245033.1
chr15
82536788
82573194
-
DDB1
chr11
61299451
61342596
-
HLA-DRA
chr6
32439878
32445046
+
RPL37A
chr2
216498825
216579180
+
RPS15
chr19
1438358
1440494
+
RPS17
chr15
82536750
82540459
-
TMEM106C
chr12
47963569
47968878
+
XAB2
chr19
7619525
7629545
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC245033.4
chr15
82533175
82540008
-
MIR155HG
chr21
25561909
25575168
+
Display:



Experiment Detail

GEO ID:GSE25609
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL8179
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:826
Sample treatment protocol:Briefly, samples were centrifuged at 1,600×g for 10 min at 4 ºC to spin down blood cells, and plasma was transferred into new tubes, followed by further centrifugation at 16,000×g for 10 minutes at 4ºC to completely remove cellular components.
RNA Extract protocol:NA
RNA library preparation protocol:Biotinylated cDNA were prepared with the Illumina® TotalPrep™ RNA Amplification Kit (Ambion).



Reference

PMID:23267864
Title:Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study
Author:Gir¨¢ldez MD, Lozano JJ, Ram¨ªrez G, Hijona E, Bujanda L, Castells A, Gironella M
Journal:Clin Gastroenterol Hepatol. 2013 Jun;11(6):681-8.e3.
Description:We investigated whether plasma levels of miRNA can differentiate patients with CRC from healthy individuals. We also investigated whether plasma samples from patients with premalignant neoplastic lesions, such as advanced adenomas (AAs), also had a different expression pattern of miRNAs.